Continued Low Penetration of Biologics in Treatment of Psoriasis Signals Need for Enhanced Education, Safety Data to Help Patients Overcome Concerns, According to Study by GfK Market Measures
August 5, 2008 — Despite the fact biologics are considered to be the most effective option for treating severe cases of psoriasis, they have been unable to gain patients’ favor and penetrate to date as a class, according to new research by GfK Market Measures.
more >>
Fibromyalgia Patients’ Nonpain Symptoms Present Challenge for Drug Marketers Looking to Satisfy, According to Study by GfK Market Measures
July 30, 2008 — Fibromyalgia, a chronic condition within the neuropathic pain category, is complicated both in its initial diagnosis and ongoing treatment because of a wide range of pain and nonpain symptoms. The success of drugs such as Cymbalta, Lyrica and future entrants in this market are dependent on marketers having a more holistic view of patient satisfaction as well as implementing awareness and education programs for physicians and patients, according to new research by GfK Market Measures.
more >>
Physicians Report MRSA “Superbug” Cases on the Rise, According to Study by GfK Market Measures
July 29, 2008 — The prevalence of methicillin-resistant Staphylococcus aureus (MRSA), or the so-called “superbug,” is on the rise in hospitals and routinely encountered in the emergency room. While tests to detect MRSA are becoming more common, and hospitals are intensifying procedures to better control its spread, there remains a need to develop more effective treatment options, according to new research by GfK Market Measures.
more >>
Rheumatologists Report Patients’ Concern Over Infection Risk as Primary Barrier to Biologics Usage, According to Study by GfK Market Measures
July 2, 2008 — Despite the fact that biologics represent a sea change in medication effectiveness for the treatment of rheumatoid arthritis and other autoimmune disorders, potential safety concerns stemming from increased risk of infection are having a negative influence on patients’ decision to trial the therapy, according to new research by GfK Market Measures.
more >>
GfK Market Measures Launches Marketing Research Unit Dedicated to Medical and Surgical Devices
July 1, 2008 — In response to the medical and surgical device industry’s growing need for more robust information and insights to support market strategy in an increasingly demanding market, GfK Market Measures has established a dedicated business unit,
MedSurg Insight™, offering marketing research and consulting to address the unique challenges of device manufacturers.
more >>
